New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools

Published:2019-06-03 Issue:1 Volume:38 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Muñoz-Galván Sandra,Felipe-Abrio Blanca,García-Carrasco Miguel,Domínguez-Piñol Julia,Suarez-Martinez Elisa,Verdugo-Sivianes Eva M.,Espinosa-Sánchez Asunción,Navas Lola E.,Otero-Albiol Daniel,Marin Juan J.,Jiménez-García Manuel P.,García-Heredia Jose M.,Quiroga Adoración G.,Estevez-Garcia Purificacion,Carnero Amancio

Funder

Instituto de Salud Carlos III

Ministerio de Economía y Competitividad

Centro de Investigación Biomédica en Red Cáncer

Consejería de Salud, Junta de Andalucía

Ministerio de Ciencia, Innovación y Universidades

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-019-1245-5.pdf

Reference49 articles.

1. The L. GLOBOCAN 2018: counting the toll of cancer. Lancet. 2018;392(10152):985.

2. Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016;2:16061.

3. Karam A, Ledermann JA, Kim JW, Sehouli J, Lu K, Gourley C, et al. Fifth ovarian Cancer consensus conference of the gynecologic Cancer InterGroup: first-line interventions. Ann Oncol. 2017;28(4):711–7.

4. Pignata S, Scambia G, Ferrandina G, Savarese A, Sorio R, Breda E, et al. Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial. J Clin Oncol. 2011;29(27):3628–35.

5. Pignata S, Cannella L, Leopardo D, Pisano C, Bruni GS, Facchini G. Chemotherapy in epithelial ovarian cancer. Cancer Lett. 2011;303(2):73–83.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and molecular features of platinum resistance in ovarian cancer;Critical Reviews in Oncology/Hematology;2024-09

2. Artificial intelligence in ovarian cancer drug resistance advanced 3PM approach: subtype classification and prognostic modeling;EPMA Journal;2024-07-13

3. Advances in ovarian tumor stem cells and therapy;Cell Biochemistry and Biophysics;2024-07-03

4. Protein homeostasis maintained by HOOK1 levels promotes the tumorigenic and stemness properties of ovarian cancer cells through reticulum stress and autophagy;Journal of Experimental & Clinical Cancer Research;2024-05-29

5. Drug resistance in ovarian cancer: from mechanism to clinical trial;Molecular Cancer;2024-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3